Rheumatoid arthritis - adalimumab, etanercept, infliximab, certolizumab pegol, golimumab, abatacept and tocilizumab - review [ID537]: committee papers (appendices 1-3)
This page was last updated: 19 June 2015
This page was last updated: 19 June 2015